Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Horizon Lines: A Quarterly Review of NDAs – October- December 2025
This quarterly review of New Drug Applications contains data for applications approved for the first time during the last quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 40 applications were approved by the FDA during these three months. read more
An Interview With Kim Boericke
Veristat’s new CEO, Kim McLean Boericke, is one step closer to changing the tide in representing the small fraction of companies led by women and is now the only female with the highest job among the top-8 clinical research organizations (CROs). read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
Five Steps to Smooth Agentic AI Adoption
In agentic AI-enabled labs, AI goes from individual, one-off applications to comprehensive workflow orchestration. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Ecolab Opens Resin Manufacturing Facility in China
Tuesday, September 15, 2026
Ecolab Life Sciences has opened a resin manufacturing facility in Quzhou, China, expanding the company’s capacity to produce materials used in ... read more
Endpoint Clinical Acquires Bluefin
Tuesday, September 15, 2026
Endpoint Clinical has acquired Bluefin, a provider of clinical supply forecasting and planning technology. read more
FAREVA Acquires Pharmaceutical Manufacturing Site in Türkiye
Tuesday, September 15, 2026
FAREVA has acquired a pharmaceutical production site in Lüleburgaz, Türkiye, expanding its manufacturing network and adding nearly 750 employees. read more
Sygnature Discovery Establishes DEL Screening Collaboration with X-Chem
Monday, September 14, 2026
Sygnature Discovery has established a formal collaboration with X-Chem to support the delivery of DEL screening within its integrated drug discovery ... read more
Transcenta Licenses Continuous Bioprocessing Technology to WuXi Biologics
Thursday, September 10, 2026
Transcenta Therapeutics and WuXi Biologics have entered a technology licensing and strategic collaboration agreement covering Transcenta’s HiCB ... read more